The E7 oncoprotein of human papillomavirus type 16 interacts with F- actin in vitro and in vivo

Virology

Volumn 268, Issue 2, 2000, Pages 372-381

  Rey, Osvaldo ^a   Lee, Sora ^a   Baluda, Marcel A ^a   Swee, Jerry ^a   Ackerson, Bradley ^a   Chiu, Robert ^a   Park, No Hee ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytoskeleton; E7 oncoprotein; HPV; Viral carcinogenesis

Indexed keywords

ACTIN BINDING PROTEIN; CASEIN KINASE II; HEPARIN; ONCOPROTEIN; SERINE;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; WART VIRUS;

ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; ORYCTOLAGUS CUNICULUS; VACCINIA; VACCINIA VIRUS;

EID: 0034654054     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0175     Document Type: Article

References (52)

1. Assoian R. K., Zhu X. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr. Opin. Cell Biol. 9:1997;93-98.
2. Ausubel F. M. Current Protocols in Molecular Biology. 1987;Greene and Wiley-Interscience, New York.
3. Bablanian R. Structural and functional alterations in cultured cells infected with cytocidal viruses. Melnick J. Progress in Medical Virology. 1975;41-75 Karger, Basel.
4. Bablanian R., Baxt B., Sonnabend J. A., Esteban M. Studies on the mechanisms of vaccinia virus cytopathic effects. II. Early cell rounding is associated with virus polypeptide synthesis. J. Gen. Virol. 39:1978;403-413.
5. Baker C. C., Phelps W. C., Lindgren V., Braun M. J., Gonda M. A., Howley P. M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:1987;962-971.
6. Barbosa M. S., Edmonds C., Fisher C., Schiller J. T., Lowy D. R., Vousden K. H. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J. 9:1990;153-160.
7. Ben-Ze'ev A. Cytoskeletal and adhesion proteins as tumor suppressors. Curr. Opin. Cell Biol. 9:1997;99-108.
8. Bernard H. U., Oltersdorf T., Seedorf K. Expression of the human papillomavirus type 18 E7 gene by a cassette-vector system for the transcription and translation of open reading frames in eukaryotic cells. EMBO J. 6:1987;133-138.
9. Bershadsky A. D., Vasiliev I. U. M. Cellular organelles. Hennelly M. Cytoskeleton. 1988;91-98 Plenum, New York.
10. Biswas S. K., Nayak D. P. Influenza virus polymerase basic protein 1 interacts with influenza virus polymerase basic protein 2 at multiple sites. J. Virol. 70:1996;6716-6722.
11. Bohn W., Rutter G., Hohenberg H., Mannweiler K., Nobis P. Involvement of actin filaments in budding of measles virus: Studies on cytoskeletons of infected cells. Virology. 149:1986;91-106.
12. Burke E., Dupuy L., Wall C., Barik S. Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus. Virology. 252:1998;137-148.
13. Chiu F. C., Goldman J. E. Synthesis and turnover of cytoskeletal proteins in cultured astrocytes. J. Neurochem. 42:1984;166-174.
14. Cudmore S., Cossart P., Griffiths G., Way M. Actin-based motility of vaccinia virus. Nature. 378:1995;636-638.
15. Davey J., Colman A., Dimmock N. J. Location of influenza virus M, NP and NS1 proteins in microinjected cells. J. Gen. Virol. 66:1985;2319-2334.
16. Edelman A. M., Blumenthal D. K., Krebs E. G. Protein serine/threonine kinases. Annu. Rev. Biochem. 56:1987;567-613.
17. Edmonds C., Vousden K. H. A point mutational analysis of human papillomavirus type 16 E7 protein. J. Virol. 63:1989;2650-2656.
18. Feige J. J., Pirollet F., Cochet C., Chambaz E. M. Selective inhibition of a cyclic nucleotide-independent protein kinase (G-type casein kinase) by naturally occurring glycosaminoglycans. FEBS Lett. 121:1980;139-142.
19. Felice G. R., Eason P., Nermut M. V., Kellie S. pp60v-src association with the cytoskeleton induces actin reorganization without affecting polymerization status. Eur. J. Cell Biol. 52:1990;47-59.
20. Fey E. G., Penman S. The morphological oncogenic signature: Reorganization of epithelial cytoarchitecture and metabolic regulation by tumor promoters and by transformation. Dev. Biol. 3:1985;81-100.
21. Filhol O., Cochet C., Chambaz E. M. Cytoplasmic and nuclear distribution of casein kinase II: Characterization of the enzyme uptake by bovine adrenocortical nuclear preparation. Biochemistry. 29:1990;9928-9936.
22. Firzlaff J. M., Galloway D. A., Eisenman R. N., Luscher B. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II. New Biologist. 1:1989;44-53.
23. Fuerst T. R., Earl P. L., Moss B. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 7:1987;2538-2544.
24. Hathaway G. M., Lubben T. H., Traugh J. A. Inhibition of casein kinase II by heparin. J. Biol. Chem. 255:1980;8038-8041.
25. Hathaway G. M., Traugh J. A. Casein kinases - Multipotential protein kinases. Curr. Top. Cell Regul. 21:1982;101-127.
26. Jackson R., Hunt T. Preparation and use of nuclease-treated rabbit reticulocyte lysates for the translation of eukariotic messenger RNA. Fleisher S., Fleischer B. Methods in Enzymology. 1983;50-74 Academic Press, New York.
27. Janmey P. A., Chaponnier C. Medical aspects of the actin cytoskeleton. Curr. Opin. Cell Biol. 7:1995;111-117.
28. Kanda T., Zanma S., Watanabe S., Furuno A., Yoshiike K. Two immunodominant regions of the human papillomavirus type 16 E7 protein are masked in the nuclei of monkey COS-1 cells. Virology. 182:1991;723-731.
29. Kandror K. V., Benumov A. O., Stepanov A. S. Casein kinase II from Rana temporaria oocytes. Intracellular localization and activity during progesterone-induced maturation. Eur. J. Biochem. 180:1989;441-448.
30. Ke L. D., Adler-Storthz K., Mitchell M. F., Clayman G. L., Chen Z. Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines. Oral Oncol. 35:1999;415-420.
31. Kreis T., Vale R. Guidebook to the Cytoskeletal and Motor Proteins. 1993;Oxford Univ. Press, Oxford, New York.
32. Kreis T. E., Winterhalter K. H., Birchmeier W. In vivo distribution and turnover of fluorescently labeled actin microinjected into human fibroblasts. Proc. Natl. Acad. Sci. USA. 76:1979;3814-3818.
33. Lane D., Harlow E. Antibodies: A Laboratory Manual. 1988;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 386-387.
34. Liu X., Han S., Baluda M. A., Park N. H. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes. Oncogene. 14:1997;2347-2353.
35. Los Alamos National Laboratory Web site, 1997, Cellular proteins. Human Papillomavvirus 1997 Compendium, http://linker.lanl.gov/stdgen/virus/hpv/compendium/htdocs/HTML_FILES/ , IV-1-4.
36. Maenpaa P. H. Effects of polyamines and polyanions on a cyclic nucleotide-independent and a cyclic AMP-dependent protein kinase. Biochim. Biophys. Acta. 498:1977;294-305.
37. Martin J., Sugden B. Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association. J. Virol. 65:1991;3246-3258.
38. Matsudaira P. Mapping structural and functional domains in actin-binding proteins. Carraway K. L., Carraway C. A. C. The Cytoskeleton: A Practical Approach. 1992;73-98 IRL Press at Oxford Univ. Press, Oxford, New York.
39. McCormack S. J., Brazinski S. E., Moore J. L. Jr., Werness B. A., Goldstein D. J. Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene. 15:1997;265-274.
40. Meisner H., Czech M. P. Phosphorylation of transcriptional factors and cell-cycle-dependent proteins by casein kinase II. Curr. Opin. Cell Biol. 3:1991;474-483.
41. Munger K., Phelps W. C. The human papillomavirus E7 protein as a transforming and transactivating factor. Biochim. Biophys. Acta. 1155:1993;111-123.
42. Park N. H., Min B. M., Li S. L., Huang M. Z., Cherick H. M., Doniger J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis. 12:1991;1627-1631.
43. Rey O., Canon J., Krogstad P. HIV-1 Gag protein associates with F-actin present in microfilaments. Virology. 220:1996;530-534.
44. Rey O., Nayak D. P. Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear export of viral ribonucleoproteins. J. Virol. 66:1992;5815-5824.
45. Rubinstein N., Chi J., Holtzer H. Coordinated synthesis and degradation of actin and myosin in a variety of myogenic and non-myogenic cells. Exp. Cell Res. 97:1976;387-393.
46. Sagara J., Tsukita S., Yonemura S., Kawai A. Cellular actin-binding ezrin-radixin-moesin (ERM) family proteins are incorporated into the rabies virion and closely associated with viral envelope proteins in the cell. Virology. 206:1995;485-494.
47. Schliwa M. The Cytoskeleton: An Introductory Survey. 1986;Springer-Verlag, Vienna, New York.
48. INK4a. Exp. Cell Res. 237:1997;7-13.
49. Singh T. J., Huang K. P. Glycogen synthase (casein) kinase-1: Tissue distribution and subcellular localization. FEBS Lett. 190:1985;84-88.
50. Tong X., Howley P. M. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc. Natl. Acad. Sci. USA. 94:1997;4412-4417.
51. Tong X., Salgia R., Li J. L., Griffin J. D., Howley P. M. The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase. J. Biol. Chem. 272:1997;33373-33376.
52. zur Hausen H., de Villiers E. M. Human papillomaviruses. Annu. Rev. Microbiol. 48:1994;427-447.